Seasonal variation, treatment outcome, and its associated factors among the snakebite patients in Somali region, Ethiopia

Background Snakebite is a major cause of mortality and morbidity in many areas, particularly in the rural tropics, and is a major public health problem around the world. It also imposes significant economic burdens on snakebite victims due to treatment-related expenses and lost productivity. Objective The purpose of this study was to assess seasonal variation, treatment outcomes, and its associated factors among snakebite in Denan health center in the Somali region, Ethiopia. Method A facility-based cross-sectional study was conducted from 10 to 30 September 2020 in Denan health center, Somali region, Ethiopia. All snakebite cases in Denan health center from 1 September 2015 to 31 August 2020 were included. Data were collected using a pre-tested structured checklist from the patient cards. Data were entered into EpiData version 3.1 and analyzed using SPSS version 22 (IBM SPSS Statistics, 2013). The prevalence was reported by proportion with 95% confidence interval (CI) and summary measures. Predictors were assessed using a multivariable logistic regression analysis model and reported using an adjusted odds ratio with 95% CI. Statistical significance was declared at p-value < 0. 05. Result The overall prevalence of poor outcome of venomous snakebites was 31.4% (95% CI 26.3% 35.4%). Study participants with an age of less than 10 years old (AOR = 2.01; 95% CI 1.39, 4.05), age between 10 and 30 years old (AOR = 2.06; 95% CI 1.39, 9.30), arrival times greater than or equal to 6 hours (AOR = 2.37; 95% CI 1.39, 4.05), and timing of snakebite (AOR = 0.49; 95% CI 0.31–0.87) were factors found to be significantly associated with poor treatment outcome. Conclusion According to this study, about one in every three snakebite patients have a poor outcome. Patients with poor outcomes were those who did not improve as a result of treatment or died as a result of it. Designing appropriate engagement of public health education about snakebite prevention techniques, particularly during entry and exit of rainy seasons and establishment of appropriate case management protocol is strongly recommended, as well as increasing the accessibility or availability of antivenoms will undoubtedly have a significant impact on the reduction of mortality and disability related to that of the snakebites.

[1]  F. Chappuis,et al.  Assessment of the effect of snakebite on health and socioeconomic factors using a One Health perspective in the Terai region of Nepal: a cross-sectional study. , 2022, The Lancet. Global health.

[2]  K. Ritmeijer,et al.  Treatment outcomes among snakebite patients in north-west Ethiopia—A retrospective analysis , 2022, PLoS neglected tropical diseases.

[3]  M. Sasa,et al.  New insights into snakebite epidemiology in Costa Rica: A retrospective evaluation of medical records , 2020, Toxicon: X.

[4]  J. Cordovez,et al.  Estimating snakebite incidence from mathematical models: A test in Costa Rica , 2019, PLoS neglected tropical diseases.

[5]  N. Bathula,et al.  Hepatoprotective activity of ethanolic and aqueous extract of Turnera aphrodisiaca leaves against CCl4-induced liver injury in rats , 2019, International Journal of Basic & Clinical Pharmacology.

[6]  G. Lipman,et al.  Snakebites and climate change in California, 1997–2017 , 2018, Clinical toxicology.

[7]  F. Carvalho,et al.  Time to treatment and severity of snake envenoming in Brazil , 2018, Revista panamericana de salud publica = Pan American journal of public health.

[8]  David J. Williams,et al.  Epidemiological Survey of Snake Bite in Ethiopia , 2014 .

[9]  Fabricio González-Andrade,et al.  Snake bite envenomation in Ecuador. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  David J. Williams,et al.  The Global Snake Bite Initiative: an antidote for snake bite , 2010, The Lancet.

[11]  A. Kasturiratne,et al.  The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths , 2008, PLoS medicine.

[12]  J. Gutiérrez,et al.  Confronting the Neglected Problem of Snake Bite Envenoming: The Need for a Global Partnership , 2006, PLoS medicine.

[13]  S. Mustapha Snake bite in Gombe , 2005 .

[14]  D. Warrell,et al.  Clinical Toxinology—Where Are We Now? , 2003, Journal of toxicology. Clinical toxicology.

[15]  D. Warrell,et al.  Antivenom Treatment in Arachnidism , 2003, Journal of toxicology. Clinical toxicology.

[16]  Julian White,et al.  Bites and stings from venomous animals: a global overview. , 2000, Therapeutic drug monitoring.

[17]  D. Smith,et al.  First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. , 1997, The American journal of tropical medicine and hygiene.

[18]  D. L. Hardy Bothrops asper (Viperidae) snakebite and field researchers in Middle America , 1994 .

[19]  G. Muguti,et al.  Snake bites in Zimbabwe: a clinical study with emphasis on the need for antivenom. , 1994, The Central African journal of medicine.

[20]  B. Currie,et al.  An epidemiological study of snake bite envenomation in Papua New Guinea , 1991, The Medical journal of Australia.

[21]  Kassa Tameru Snake bite envenomation at Aysha refugee camp health center. , 2006, Ethiopian medical journal.

[22]  W. Hayes,et al.  FACTORS THAT INFLUENCE VENOM EXPENDITURE IN VIPERIDS AND OTHER SNAKE SPECIES DURING PREDATORY AND DEFENSIVE CONTEXTS , 2002 .

[23]  J. Chippaux,et al.  Snake-bites: appraisal of the global situation. , 1998, Bulletin of the World Health Organization.

[24]  J. Chippaux,et al.  Snake venom variability: methods of study, results and interpretation. , 1991, Toxicon : official journal of the International Society on Toxinology.

[25]  S. Swaroop.,et al.  Snakebite mortality in the world. , 1954, Bulletin of the World Health Organization.